| New approaches to the treatment of hypertension. | |
| | |
MedLine Citation:
|
PMID: 1801895 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
In the past, therapy of hypertension has not provided protection against coronary heart disease. The possible reasons are multiple and likely will never be fully ascertained. Nonetheless, numerous changes in therapy can be made that should reduce coronary risk. These include more careful monitoring of the blood pressure with particular care for control of high levels during the early morning hours; attention to all alterable risk factors with care to avoid worsening of other risks with antihypertensive drugs; adroit use of nondrug therapies; and, when drugs are used, the pressure should be lowered slowly and only to a level that avoids coronary hypoperfusion. |
| | |
Authors:
|
N M Kaplan |
Related Documents
:
|
19587555 - Achieving blood pressure goals: should angiotensin ii receptor blockers become first-li... 15990175 - Reduction of blood pressure variability: a new strategy for the treatment of hypertension. 7356865 - Long-term antihypertensive drug treatment and blood pressure control in three hospital ... 17173495 - Hypertension, possible vascular protection and lercanidipine. 8884415 - Effect of strength training on blood pressure measured in various conditions in sedenta... 15636555 - Noninvasive mechanical ventilation of mice by using a balloon-tipped cannula. |
Publication Detail:
|
Type: Journal Article; Review |
Journal Detail:
|
Title: Cardiovascular drugs and therapy / sponsored by the International Society of Cardiovascular Pharmacotherapy Volume: 5 ISSN: 0920-3206 ISO Abbreviation: Cardiovasc Drugs Ther Publication Date: 1991 Dec |
Date Detail:
|
Created Date: 1992-04-29 Completed Date: 1992-04-29 Revised Date: 2005-11-16 |
Medline Journal Info:
|
Nlm Unique ID: 8712220 Medline TA: Cardiovasc Drugs Ther Country: UNITED STATES |
Other Details:
|
Languages: eng Pagination: 973-8 Citation Subset: IM |
Affiliation:
|
University of Texas Southwestern Medical Center, Dallas 75235-8899. |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Drug Therapy
/
trends Humans Hypertension / drug therapy, therapy* Risk Factors |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Calcium-sensitizing inotropic agents in the treatment of heart failure: a critical view.
Next Document: The level at which blood pressure should be treated.